What is the optimal timing for pneumococcal (PCV13, PPSV23), meningococcal (MenACWY), Haemophilus influenzae type b (Hib), and influenza vaccinations in patients undergoing elective versus urgent splenectomy, and the subsequent booster schedule?

Optimal Timing for Splenectomy Vaccinations

Elective Splenectomy: Pre-operative Vaccination is Mandatory

All vaccines (pneumococcal, meningococcal, Haemophilus influenzae type b, and influenza) must be administered at least 2 weeks before elective splenectomy, with an ideal window of 2-6 weeks pre-operatively to ensure optimal antibody response before the patient becomes functionally asplenic. 1, 2, 3

Why Pre-operative Timing Matters

• The 2-week minimum allows adequate time for antibody production and results in significantly higher antibody concentrations compared to vaccination at shorter intervals or post-operatively 1, 4
• Functional antibody activity (measured by opsonophagocytosis) is substantially reduced when vaccines are given immediately after surgery, with progressive improvement when vaccination is delayed to 14 days post-operatively 4
• Pre-operative vaccination protects patients during the immediate post-surgical period when they are most vulnerable 1, 2

Urgent/Emergency Splenectomy: Post-operative Protocol

For trauma or emergency splenectomy where pre-operative vaccination is impossible, administer all vaccines at least 14 days after surgery once the patient is clinically stable. 1, 2, 5

• Do not vaccinate earlier than 14 days post-operatively—earlier administration yields insufficient antibody responses and poor functional antibody activity 1, 4
• All indicated vaccines may be given simultaneously at separate injection sites without compromising immunogenicity 1

---

Pneumococcal Vaccination: Sequential Prime-Boost Strategy

Initial Series

Begin with PCV13, PCV15, or PCV20 (conjugate vaccine), then administer PPSV23 at least 8 weeks later—never simultaneously. 1, 2, 3

• The sequential "prime-boost" strategy produces superior antibody responses compared to PPSV23 alone 1
• For vaccine-naïve patients aged ≥2 years, this conjugate-first approach is mandatory 1, 3

Booster Schedule

• First PPSV23 booster: Administer exactly 5 years after the initial PPSV23 dose 1, 2, 3
• Subsequent boosters: Revaccinate with PPSV23 every 5-10 years for lifelong protection 6, 1, 2
• Antibody levels decline more rapidly in asplenic patients than expected, justifying this aggressive revaccination schedule 6

Clinical Rationale

• Streptococcus pneumoniae accounts for approximately 50% of overwhelming post-splenectomy infections (OPSI) 1, 2
• The 23-valent polysaccharide vaccine is more than 90% effective in healthy adults under age 55 6, 2

---

Meningococcal Vaccination: Dual Requirement (MenACWY + MenB)

Critical Pitfall to Avoid

Both MenACWY and MenB vaccines are mandatory—not optional—because meningococcal disease carries 40-70% mortality in asplenic patients. 1, 3

MenACWY Protocol

• Initial series: Administer 2 doses given at least 8 weeks apart for patients aged ≥10 years (this is a 2-dose series, not the single dose used in healthy adults) 1, 2, 3
• Booster schedule: Revaccinate every 5 years for life 1, 2, 3
• Do not use MenACWY-D in children <2 years with asplenia—it reduces pneumococcal vaccine response 1

MenB Protocol

• Initial series: Either MenB-FHbp (3 doses at 0,1-2, and 6 months) OR MenB-4C (2 doses at least 1 month apart) 1
• Booster schedule: Single dose at 1 year after primary series, then every 2-3 years if risk persists 1, 2
• Serogroup B causes approximately 40% of meningococcal cases in high-risk populations 1

---

Haemophilus Influenzae Type b (Hib) Vaccination

Administer one dose of Hib conjugate vaccine to all unvaccinated asplenic persons aged ≥5 years. 1, 2, 3

• No revaccination is needed if the patient completed the standard childhood Hib series 1
• Timing should follow the same 2-week pre-surgery guideline for elective cases or 14-day post-surgery for emergency cases 1

---

Influenza Vaccination: Annual Requirement

All asplenic patients aged ≥6 months must receive annual inactivated influenza vaccine (IIV). 1, 3

• Never use live attenuated influenza vaccine (LAIV/nasal spray) in asplenic patients 1, 3
• Although baseline influenza risk is not higher, infection can precipitate secondary bacterial pneumonia and sepsis with devastating consequences 1
• Influenza vaccination reduces mortality by approximately 54% compared with unvaccinated controls in this population 1

---

Essential Non-Vaccine Preventive Measures

Lifelong Antibiotic Prophylaxis

• Prescribe lifelong prophylactic phenoxymethylpenicillin, with highest priority in the first 2 years post-splenectomy 6, 1, 2
• For penicillin-allergic patients, substitute erythromycin 6
• Provide emergency standby antibiotics (amoxicillin) for home use at the first sign of fever, malaise, or chills 6, 1, 2

Patient Education and Documentation

• Educate patients about lifelong infection risk and the need for immediate medical attention for fever >101°F (38°C) 1, 2, 3
• Issue medical alert identification (card or bracelet) indicating asplenic status 1, 2
• Formally notify primary care providers of the patient's asplenic status to ensure appropriate ongoing care 6, 2

Special Situations

• After dog or animal bites, asplenic patients require a 5-day course of co-amoxiclav due to susceptibility to Capnocytophaga canimorsus 2
• Patients taking erythromycin should seek immediate medical help for any feverish illness 6

---

Risk Magnitude Justifying These Measures

• The lifelong risk of OPSI carries mortality rates of 30-70% 1, 2, 3
• Though most infections occur within the first 2 years after splenectomy, up to one-third manifest at least 5 years later 6
• Cases of fulminant infection have been reported more than 20 years after splenectomy, confirming lifelong risk 6, 1, 2
• The risk of dying from serious infection is clinically significant and almost certainly lifelong 6

---

Common Pitfalls Summary

• Do NOT skip pre-operative vaccination for elective cases—waiting until post-operatively yields inferior immune responses 1, 4
• Do NOT treat asplenic patients like routine adults—they require enhanced 2-dose MenACWY series, not a single dose 1
• Do NOT skip MenB vaccination—it is mandatory, not optional 1, 3
• Do NOT forget lifelong revaccination—protection wanes and infection risk persists for life 1, 2
• Do NOT vaccinate earlier than 14 days post-operatively in emergency cases—functional antibody responses are inadequate 1, 4